Michael Cloonan
Director/Miembro de la Junta en BLUEBIRD BIO, INC. .
Cargos activos de Michael Cloonan
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| BLUEBIRD BIO, INC. | Director/Miembro de la Junta | 20/06/2024 | - |
RA Capital Management LP (Private Equity)
 RA Capital Management LP (Private Equity) Investment ManagersFinance RA Capital Management LP (Private Equity) (RA Capital) is a private equity & venture capital subsidiary of RA Capital Management LP founded by Peter Kolchinsky in 2004. The firm is headquartered in Boston, MA. | Consultor / Asesor | - | - |
Sionna Therapeutics, Inc.
 Sionna Therapeutics, Inc. Medical/Nursing ServicesHealth Services Sionna Therapeutics, Inc. is a clinical-stage life sciences company located in Natick, MA. The company is dedicated to developing highly effective and differentiated treatments for cystic fibrosis (CF) by normalizing the function of CFTR, the key protein associated with disease progression in CF. Sionna is advancing a pipeline of small molecules engineered to correct the protein defects caused by ?F508, the most common mutation that affects the CFTR protein. The company has a first-in-class portfolio of programs directly targeting correction of ?F508-CFTR, the key and unique mechanism to enable full restoration of ?F508-CFTR function, and complementary programs targeting ICL4 and more. The CEO of the company is Michael Cloonan. | Director/Miembro de la Junta | - | - |
| Director Ejecutivo | - | - | |
| Presidente | - | - |
Historial de carrera de Michael Cloonan
Antiguos cargos conocidos de Michael Cloonan.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| SAGE THERAPEUTICS, INC. | Director de Operaciones | 01/05/2020 | 03/05/2021 |
| Corporate Officer/Principal | 24/04/2017 | 01/05/2020 | |
| BIOGEN INC. | Corporate Officer/Principal | 01/01/2003 | 01/01/2017 |
Formación de Michael Cloonan.
| University of Virginia Darden School of Business | Masters Business Admin |
| College of the Holy Cross (Massachusetts) | Undergraduate Degree |
Estadísticas
Internacional
| Estados Unidos | 8 |
Operativa
| Corporate Officer/Principal | 2 |
| Director/Board Member | 2 |
| Chief Operating Officer | 1 |
Sectorial
| Health Technology | 4 |
| Consumer Services | 3 |
| Finance | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 3 |
|---|---|
| SAGE THERAPEUTICS, INC. | Health Technology |
| BIOGEN INC. | Health Technology |
| BLUEBIRD BIO, INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
RA Capital Management LP (Private Equity)
RA Capital Management LP (Private Equity) Investment ManagersFinance RA Capital Management LP (Private Equity) (RA Capital) is a private equity & venture capital subsidiary of RA Capital Management LP founded by Peter Kolchinsky in 2004. The firm is headquartered in Boston, MA. | Finance |
Sionna Therapeutics, Inc.
Sionna Therapeutics, Inc. Medical/Nursing ServicesHealth Services Sionna Therapeutics, Inc. is a clinical-stage life sciences company located in Natick, MA. The company is dedicated to developing highly effective and differentiated treatments for cystic fibrosis (CF) by normalizing the function of CFTR, the key protein associated with disease progression in CF. Sionna is advancing a pipeline of small molecules engineered to correct the protein defects caused by ?F508, the most common mutation that affects the CFTR protein. The company has a first-in-class portfolio of programs directly targeting correction of ?F508-CFTR, the key and unique mechanism to enable full restoration of ?F508-CFTR function, and complementary programs targeting ICL4 and more. The CEO of the company is Michael Cloonan. | Health Services |
- Bolsa de valores
- Insiders
- Michael Cloonan
- Experiencia
